Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients
- PMID: 20142916
- PMCID: PMC2813138
- DOI: 10.4103/0971-4065.43690
Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients
Abstract
A cross-sectional study was performed from November 2005 to July 2007 to determine the prevalence of microalbuminuria and its risk factors among type 2 diabetic patients.. Two hundred and eighty-eight type 2 diabetic patients (141 males and 147 females) referred to Yazd diabetes research center were randomly recruited for the study. Microalbuminuria was detected by measuring the albumin to creatinine ratio in the early morning urine. Microalbuminuria was diagnosed if this ratio was between 30 and 300 mg/g on two occasions during three months. Prevalence of microalbuminuria was 14.2%. Chi-square analysis revealed that microalbuminuria was correlated with the diastolic blood pressure (P = 0.003) and the duration of diabetes (P = 0.000). No statistically significant correlation was found between microalbuminuria and age, sex, body mass index, levels of fasting blood sugar, glycosylated hemoglobin (HbA1c), serum triglyceride, and serum cholesterol, or systolic blood pressure. For 240 patients for whom the duration of diabetes was known from the answers in their questionnaires, logistic regression was used for analysis. Results showed that two variables including the duration of diabetes and Diastolic Blood Pressure (DBP) play a role in this model and the following Logic association was obtained: g; (x) = -9.233 +/- 0.079 DBP +/- 0.114 duration according to this model, both DBP and duration of diabetes were directly correlated with microalbuminuria. Determination of the urine albumin to creatinine ratio is an easy method for screening of microalbuminuria that is suggested for all diabetic patients, especially diabetic patients with hypertension and long-term diabetes.
Keywords: Glycosylated hemoglobin; microalbuminuria; type 2 diabetes mellitus.
Conflict of interest statement
References
-
- Defronzo RA. Pathogenesis of type 2 diabetes. Diabetes Rev. 1997;5:177.
-
- Battisti WP, Palmisano J, Keane WE. Dyslipidemia in patients with type 2 diabetes: Relationships between lipids, kidney disease and cardiovascular disease. Clin Chem Lab Med. 2003;41:1174–81. - PubMed
-
- Raij L. Recommendations for the management of special populations: Renal disease in diabetes. Am J Hypertens. 2003;16:46S–9S. - PubMed
-
- Mogenson CE. Preventing end stage renal disease. Diabetes Med. 1998;15:S51–6. - PubMed
-
- Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes. N Engl J Med. 1999;341:1127–33. - PubMed
LinkOut - more resources
Full Text Sources